Literature DB >> 26354594

Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.

Zsofia Lenkey1,2,3, Akos Varga-Szemes1,2, Tamas Simor1,2,3, Rob J van der Geest4, Robert Kirschner1,2, Levente Toth1,2, Tamas Bodnar1,2, Brigitta C Brott5, Ada Elgavish2,6, Gabriel A Elgavish1,2.   

Abstract

PURPOSE: To test whether signal intensity percent infarct mapping (SI-PIM) accurately determines the size of myocardial infarct (MI) regardless of infarct age.
MATERIALS AND METHODS: Forty-five swine with reperfused MI underwent 1.5T late gadolinium enhancement (LGE) magnetic resonance imaging (MRI) after bolus injection of 0.2 mmol/kg Gd(DTPA) on days 2-62 following MI. Animals were classified into acute, healing, and healed groups by pathology. Infarct volume (IV) and infarct fraction (IF) were determined by two readers, using binary techniques (including 2-5 standard deviations [SD] above the remote, and full-width at half-maximum) and the SI-PIM method. Triphenyl-tetrazolium-chloride staining (TTC) was performed as reference. Bias (percent under/overestimation of IV relative to TTC) of each quantification method was calculated. Bland-Altman analysis was done to test the accuracy of the quantification methods, while intraclass correlation coefficient (ICC) analysis was done to assess intra- and interobserver agreement.
RESULTS: Bias of the MRI quantification methods do not depend on the age of the MI. Full-width at half-maximum (FWHM) and SI-PIM gave the best estimate of MI volume determined by the reference TTC (P-values for the FWHM and SI-PIM methods were 0.183, 0.26, 0.95, and 0.073, 0.091, 0.73 in Group 1, Group 2, and Group 3, respectively), while using any of the binary thresholds of 2-4 SDs above the remote myocardium showed significant overestimation. The 5 SD method, however, provided similar IV compared to TTC and was shown to be independent of the size and age of MI. ICC analysis showed excellent inter- and intraobserver agreement between the readers.
CONCLUSION: Our results indicate that the SI-PIM method can accurately determine MI volume regardless of the pathological stage of MI. Once tested, it may prove to be useful for the clinic.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  infarct quantification; late gadolinium enhancement; myocardial infarct; partial volume effect; signal intensity percent infarct mapping

Mesh:

Substances:

Year:  2015        PMID: 26354594      PMCID: PMC4786470          DOI: 10.1002/jmri.25046

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  28 in total

Review 1.  The quantification of infarct size.

Authors:  Raymond J Gibbons; Uma S Valeti; Philip A Araoz; Allan S Jaffe
Journal:  J Am Coll Cardiol       Date:  2004-10-19       Impact factor: 24.094

2.  Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution.

Authors:  Pál Surányi; Pál Kiss; Brigitta C Brott; Tamás Simor; Ada Elgavish; Balázs Ruzsics; Nada H Saab-Ismail; Gabriel A Elgavish
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

3.  Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.

Authors:  Olga Bondarenko; Aernout M Beek; Mark B M Hofman; Harald P Kühl; Jos W R Twisk; Willem G van Dockum; Cees A Visser; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

4.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.

Authors:  K C Wu; E A Zerhouni; R M Judd; C H Lugo-Olivieri; L A Barouch; S P Schulman; R S Blumenthal; J A Lima
Journal:  Circulation       Date:  1998-03-03       Impact factor: 29.690

5.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model.

Authors:  Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

6.  Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers.

Authors:  J M de Bakker; R Coronel; S Tasseron; A A Wilde; T Opthof; M J Janse; F J van Capelle; A E Becker; G Jambroes
Journal:  J Am Coll Cardiol       Date:  1990-06       Impact factor: 24.094

7.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

Authors:  M C Fishbein; S Meerbaum; J Rit; U Lando; K Kanmatsuse; J C Mercier; E Corday; W Ganz
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

8.  Histopathologic factors conducive to experimental ventricular tachycardia.

Authors:  L Wetstein; R Mark; E Kaplinsky; H Mitamura; A Kaplan; C Sauermelch; E L Michelson
Journal:  Surgery       Date:  1985-09       Impact factor: 3.982

9.  Quantitative measurement of electrical instability as a function of myocardial infarct size in the dog.

Authors:  B A Jones-Collins; R E Patterson
Journal:  Am J Cardiol       Date:  1981-11       Impact factor: 2.778

10.  Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model.

Authors:  D J Wilber; J J Lynch; D Montgomery; B R Lucchesi
Journal:  Am Heart J       Date:  1985-01       Impact factor: 4.749

View more
  1 in total

1.  Effect of inversion time on the precision of myocardial late gadolinium enhancement quantification evaluated with synthetic inversion recovery MR imaging.

Authors:  Akos Varga-Szemes; Rob J van der Geest; U Joseph Schoepf; Bruce S Spottiswoode; Carlo N De Cecco; Giuseppe Muscogiuri; Julian L Wichmann; Stefanie Mangold; Stephen R Fuller; Pal Maurovich-Horvat; Bela Merkely; Sheldon E Litwin; Rozemarijn Vliegenthart; Pal Suranyi
Journal:  Eur Radiol       Date:  2017-01-03       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.